Skip to main content
Top
Published in: Pediatric Nephrology 6/2009

Open Access 01-06-2009 | Educational Review

Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners

Authors: Deepa H. Chand, Rudolph P. Valentini, Elaine S. Kamil

Published in: Pediatric Nephrology | Issue 6/2009

Login to get access

Abstract

Recent data indicate that the incidence of end-stage renal disease (ESRD) in pediatric patients (age 0–19 years) has increased over the past two decades. Similarly, the prevalence of ESRD has increased threefold over the same period. Hemodialysis (HD) continues to be the most frequently utilized modality for renal replacement therapy in incident pediatric ESRD patients. The number of children on HD exceeded the sum total of those on peritoneal dialysis and those undergoing pre-emptive renal transplantation. Choosing the best vascular access option for pediatric HD patients remains challenging. Despite a national initiative for fistula first in the adult hemodialysis population, the pediatric nephrology community in the United States of America utilizes central venous catheters as the primary dialysis access for most patients. Vascular access management requires proper advance planning to assure that the best permanent access is placed, seamless communication involving a multidisciplinary team of nephrologists, nurses, surgeons, and interventional radiologists, and ongoing monitoring to ensure a long life of use. It is imperative that practitioners have a long-term vision to decrease morbidity in this unique patient population. This article reviews the various types of pediatric vascular accesses used worldwide and the benefits and disadvantages of these various forms of access.
Appendix
Available only for authorised users
Literature
1.
go back to reference US Renal Data System (2006) Annual data report: Atlas of end-stage renal disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006 US Renal Data System (2006) Annual data report: Atlas of end-stage renal disease in the United States, National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2006
2.
go back to reference National Kidney Foundation-Dialysis Outcomes Quality Initiative (1997) NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 30:S150–S191 National Kidney Foundation-Dialysis Outcomes Quality Initiative (1997) NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 30:S150–S191
4.
go back to reference Quinton W, Dillard D, Scribner BH (1960) Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 6:104–113PubMed Quinton W, Dillard D, Scribner BH (1960) Cannulation of blood vessels for prolonged hemodialysis. Trans Am Soc Artif Intern Organs 6:104–113PubMed
5.
go back to reference Franzone AJ, Tucker BL, Brennan LP, Fine RN, Stiles QR (1971) Hemodialysis in children. Experience with arteriovenous shunts. Arch Surg 102:592–593CrossRefPubMed Franzone AJ, Tucker BL, Brennan LP, Fine RN, Stiles QR (1971) Hemodialysis in children. Experience with arteriovenous shunts. Arch Surg 102:592–593CrossRefPubMed
6.
go back to reference Idriss FS, Nikaidoh H, King LR, Swenson O (1971) Arteriovenous shunts for hemodialysis in infants and children. J Pediatr Surg 6:639–644CrossRefPubMed Idriss FS, Nikaidoh H, King LR, Swenson O (1971) Arteriovenous shunts for hemodialysis in infants and children. J Pediatr Surg 6:639–644CrossRefPubMed
7.
go back to reference Buselmeier TJ, Kjellstrand CM, Rattazzi LC, Simmons RL, Najarian JS (1972) A new subcutaneous prosthetic A-V shunt: advantages over the standard Quinton-Scribner shunt and A-V fistula. Proc Clin Dial Transplant Forum 2:67–75PubMed Buselmeier TJ, Kjellstrand CM, Rattazzi LC, Simmons RL, Najarian JS (1972) A new subcutaneous prosthetic A-V shunt: advantages over the standard Quinton-Scribner shunt and A-V fistula. Proc Clin Dial Transplant Forum 2:67–75PubMed
8.
go back to reference Brescia MJ, Cimino JE, Appel K, Hurwich BJ (1966) Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275:1089–1092CrossRefPubMed Brescia MJ, Cimino JE, Appel K, Hurwich BJ (1966) Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275:1089–1092CrossRefPubMed
9.
go back to reference Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM (2005) Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 45:708–714CrossRefPubMed Ramage IJ, Bailie A, Tyerman KS, McColl JH, Pollard SG, Fitzpatrick MM (2005) Vascular access survival in children and young adults receiving long-term hemodialysis. Am J Kidney Dis 45:708–714CrossRefPubMed
10.
go back to reference Wander JV, Moore ES, Jonasson O (1970) Internal arteriovenous fistulae for dialysis in children. J Pediatr Surg 5:533–538CrossRefPubMed Wander JV, Moore ES, Jonasson O (1970) Internal arteriovenous fistulae for dialysis in children. J Pediatr Surg 5:533–538CrossRefPubMed
11.
go back to reference Broyer M, Loirat C, Gagnadoux MF, Cukier J, Beurton D, Vacant J (1973) By pass and arteriovenous fistula for chronic hemodialysis in children (in French). Arch Fr Pediatr 30:145–161PubMed Broyer M, Loirat C, Gagnadoux MF, Cukier J, Beurton D, Vacant J (1973) By pass and arteriovenous fistula for chronic hemodialysis in children (in French). Arch Fr Pediatr 30:145–161PubMed
12.
go back to reference Bourquelot P, Raynaud F, Pirozzi N (2003) Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases. Ther Apher Dial 7:498–503CrossRefPubMed Bourquelot P, Raynaud F, Pirozzi N (2003) Microsurgery in children for creation of arteriovenous fistulas in renal and non-renal diseases. Ther Apher Dial 7:498–503CrossRefPubMed
13.
go back to reference Gradman WS, Lerner G, Mentser M, Rodriguez H, Kamil ES (2005) Experience with autogenous arteriovenous access for hemodialysis in children and adolescents. Ann Vasc Surg 19:609–612CrossRefPubMed Gradman WS, Lerner G, Mentser M, Rodriguez H, Kamil ES (2005) Experience with autogenous arteriovenous access for hemodialysis in children and adolescents. Ann Vasc Surg 19:609–612CrossRefPubMed
14.
go back to reference Bagolan P, Spagnoli A, Ciprandi G, Picca S, Leozappa G, Nahom A, Trucchi A, Rizzoni G, Fabbrini G (1998) A ten-year experience of Brescia-Cimino arteriovenous fistula in children: technical evolution and refinements. J Vasc Surg 27:640–644CrossRefPubMed Bagolan P, Spagnoli A, Ciprandi G, Picca S, Leozappa G, Nahom A, Trucchi A, Rizzoni G, Fabbrini G (1998) A ten-year experience of Brescia-Cimino arteriovenous fistula in children: technical evolution and refinements. J Vasc Surg 27:640–644CrossRefPubMed
15.
go back to reference Bourquelot P, Cussenot O, Corbi P, Pillion G, Gagnadoux MF, Bensman A, Loirat C, Broyer M (1990) Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children. Pediatr Nephrol 4:156–159CrossRefPubMed Bourquelot P, Cussenot O, Corbi P, Pillion G, Gagnadoux MF, Bensman A, Loirat C, Broyer M (1990) Microsurgical creation and follow-up of arteriovenous fistulae for chronic haemodialysis in children. Pediatr Nephrol 4:156–159CrossRefPubMed
16.
go back to reference Garcia de Cortazar L, Gutierrez E, Delucchi MA, Cumsille MA (1999) Vascular accesses for chronic hemodialysis in children (in Spanish). Rev Med Chil 127:693–697PubMed Garcia de Cortazar L, Gutierrez E, Delucchi MA, Cumsille MA (1999) Vascular accesses for chronic hemodialysis in children (in Spanish). Rev Med Chil 127:693–697PubMed
17.
go back to reference Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N (2008) The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 23:282–287CrossRefPubMed Basile C, Lomonte C, Vernaglione L, Casucci F, Antonelli M, Losurdo N (2008) The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients. Nephrol Dial Transplant 23:282–287CrossRefPubMed
18.
go back to reference Butler HG 3rd, Baker LD Jr, Johnson JM (1977) Vascular access for chronic hemodialysis: polytetrafluoroethylene (PTFE) versus bovine heterograft. Am J Surg 134:791–793CrossRefPubMed Butler HG 3rd, Baker LD Jr, Johnson JM (1977) Vascular access for chronic hemodialysis: polytetrafluoroethylene (PTFE) versus bovine heterograft. Am J Surg 134:791–793CrossRefPubMed
19.
go back to reference Brittinger WD, Walker G, Twittenhoff WD, Konrad N (1997) Vascular access for hemodialysis in children. Pediatr Nephrol 11:87–95CrossRefPubMed Brittinger WD, Walker G, Twittenhoff WD, Konrad N (1997) Vascular access for hemodialysis in children. Pediatr Nephrol 11:87–95CrossRefPubMed
20.
go back to reference Lau KK, Jones DP, Gaber O, Nezakatgoo N (2007) Use of a “composite” vascular access graft in a young child on hemodialysis. Hemodial Int 11:190–192CrossRefPubMed Lau KK, Jones DP, Gaber O, Nezakatgoo N (2007) Use of a “composite” vascular access graft in a young child on hemodialysis. Hemodial Int 11:190–192CrossRefPubMed
21.
go back to reference Nghiem DD, Schulak JA, Corry RJ (1983) Management of the infected hemodialysis access grafts. Trans Am Soc Artif Intern Organs 29:360–362PubMed Nghiem DD, Schulak JA, Corry RJ (1983) Management of the infected hemodialysis access grafts. Trans Am Soc Artif Intern Organs 29:360–362PubMed
22.
go back to reference Bennion RS, Hiatt JR, Williams RA, Wilson SE (1985) A randomized, prospective study of perioperative antimicrobial prophylaxis for vascular access surgery. J Cardiovasc Surg (Torino) 26:270–274 Bennion RS, Hiatt JR, Williams RA, Wilson SE (1985) A randomized, prospective study of perioperative antimicrobial prophylaxis for vascular access surgery. J Cardiovasc Surg (Torino) 26:270–274
23.
go back to reference Sheth RD, Brandt ML, Brewer ED, Nuchtern JG, Kale AS, Goldstein SL (2002) Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Int 62:1864–1869CrossRefPubMed Sheth RD, Brandt ML, Brewer ED, Nuchtern JG, Kale AS, Goldstein SL (2002) Permanent hemodialysis vascular access survival in children and adolescents with end-stage renal disease. Kidney Int 62:1864–1869CrossRefPubMed
24.
go back to reference Chand DH, Brier M, Strife CF (2005) Comparison of vascular access type in pediatric hemodialysis patients with respect to urea clearance, anemia management, and serum albumin concentration. Am J Kidney Dis 45:303–308CrossRefPubMed Chand DH, Brier M, Strife CF (2005) Comparison of vascular access type in pediatric hemodialysis patients with respect to urea clearance, anemia management, and serum albumin concentration. Am J Kidney Dis 45:303–308CrossRefPubMed
25.
go back to reference Sheth RD, Kale AS, Brewer ED, Brandt ML, Nuchtern JG, Goldstein SL (2001) Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 38:553–559CrossRefPubMed Sheth RD, Kale AS, Brewer ED, Brandt ML, Nuchtern JG, Goldstein SL (2001) Successful use of Tesio catheters in pediatric patients receiving chronic hemodialysis. Am J Kidney Dis 38:553–559CrossRefPubMed
26.
go back to reference Goldstein SL, Macierowski CT, Jabs K (1997) Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 11:74–77CrossRefPubMed Goldstein SL, Macierowski CT, Jabs K (1997) Hemodialysis catheter survival and complications in children and adolescents. Pediatr Nephrol 11:74–77CrossRefPubMed
27.
go back to reference Schon D, Whittman D (2003) Managing the complications of long-term tunneled dialysis catheters. Semin Dial 16:314–322CrossRefPubMed Schon D, Whittman D (2003) Managing the complications of long-term tunneled dialysis catheters. Semin Dial 16:314–322CrossRefPubMed
28.
go back to reference Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM Jr (1999) Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 178:38–41CrossRefPubMed Petersen J, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM Jr (1999) Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 178:38–41CrossRefPubMed
29.
go back to reference Jean G, Chazot C, Vanel T, Charra B, Terrat JC, Calemard E, Laurent G (1997) Central venous catheters for haemodialysis: looking for optimal blood flow. Nephrol Dial Transplant 12:1689–1691CrossRefPubMed Jean G, Chazot C, Vanel T, Charra B, Terrat JC, Calemard E, Laurent G (1997) Central venous catheters for haemodialysis: looking for optimal blood flow. Nephrol Dial Transplant 12:1689–1691CrossRefPubMed
30.
go back to reference Saad TF (1999) Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34:1114–1124CrossRefPubMed Saad TF (1999) Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 34:1114–1124CrossRefPubMed
31.
go back to reference Beathard GA (1999) Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1045–1049PubMed Beathard GA (1999) Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 10:1045–1049PubMed
32.
go back to reference Maki DG, Ringer M, Alvarado CJ (1991) Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339–343CrossRefPubMed Maki DG, Ringer M, Alvarado CJ (1991) Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 338:339–343CrossRefPubMed
33.
go back to reference Bleyer AJ (2007) Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2:1073–1078CrossRefPubMed Bleyer AJ (2007) Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin J Am Soc Nephrol 2:1073–1078CrossRefPubMed
34.
go back to reference Valentini RP, Geary DF, Chand DH (2008) Central venous lines for chronic hemodialysis: survey of the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol 23:291–295CrossRefPubMed Valentini RP, Geary DF, Chand DH (2008) Central venous lines for chronic hemodialysis: survey of the Midwest Pediatric Nephrology Consortium. Pediatr Nephrol 23:291–295CrossRefPubMed
35.
go back to reference Hoshal VL Jr, Ause RG, Hoskins PA (1971) Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 102:253–258CrossRef Hoshal VL Jr, Ause RG, Hoskins PA (1971) Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg 102:253–258CrossRef
36.
go back to reference Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, Fessahaye A, Gupta AK (2000) Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol 11:1121–1129CrossRefPubMed Gray RJ, Levitin A, Buck D, Brown LC, Sparling YH, Jablonski KA, Fessahaye A, Gupta AK (2000) Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial. J Vasc Interv Radiol 11:1121–1129CrossRefPubMed
37.
go back to reference Twardowski ZJ (1998) High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 31:841–847CrossRefPubMed Twardowski ZJ (1998) High-dose intradialytic urokinase to restore the patency of permanent central vein hemodialysis catheters. Am J Kidney Dis 31:841–847CrossRefPubMed
38.
go back to reference Bamgbola OF, del Rio M, Kaskel FJ, Flynn JT (2005) Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance. Pediatr Nephrol 20:989–993CrossRefPubMed Bamgbola OF, del Rio M, Kaskel FJ, Flynn JT (2005) Recombinant tissue plasminogen activator infusion for hemodialysis catheter clearance. Pediatr Nephrol 20:989–993CrossRefPubMed
39.
go back to reference Chand DH, Brier ME, Strife CF (2007) Effects of demographic characteristics and medical care before starting hemodialysis on vascular access in incident pediatric hemodialysis patients. Pediatr Nephrol 22:1570 (abstract 641) Chand DH, Brier ME, Strife CF (2007) Effects of demographic characteristics and medical care before starting hemodialysis on vascular access in incident pediatric hemodialysis patients. Pediatr Nephrol 22:1570 (abstract 641)
40.
go back to reference Davidson I, Gallieni M, Saxena R, Dolmatch B (2007) A patient centered decision making dialysis access algorithm. J Vasc Access 8:59–68CrossRefPubMed Davidson I, Gallieni M, Saxena R, Dolmatch B (2007) A patient centered decision making dialysis access algorithm. J Vasc Access 8:59–68CrossRefPubMed
41.
go back to reference Turmel-Rodrigues LA, Bourquelot P, Pengloan J (2003) Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology 227:906–907; author reply 907CrossRefPubMed Turmel-Rodrigues LA, Bourquelot P, Pengloan J (2003) Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology 227:906–907; author reply 907CrossRefPubMed
42.
go back to reference Chand DH, Poe SA, Strife CF (2002) Venous pressure monitoring does not accurately predict access failure in children. Pediatr Nephrol 17:765–769CrossRefPubMed Chand DH, Poe SA, Strife CF (2002) Venous pressure monitoring does not accurately predict access failure in children. Pediatr Nephrol 17:765–769CrossRefPubMed
43.
go back to reference Goldstein SL, Smith CM, Currier H (2003) Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol 14:2127–2131CrossRefPubMed Goldstein SL, Smith CM, Currier H (2003) Noninvasive interventions to decrease hospitalization and associated costs for pediatric patients receiving hemodialysis. J Am Soc Nephrol 14:2127–2131CrossRefPubMed
44.
go back to reference National Kidney Foundation (2006) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy, Vascular Access. Am J Kidney Dis 48(Suppl 1):S274–276 National Kidney Foundation (2006) KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for 2006 Updates: Hemodialysis Adequacy, Peritoneal Dialysis Adequacy, Vascular Access. Am J Kidney Dis 48(Suppl 1):S274–276
Metadata
Title
Hemodialysis vascular access options in pediatrics: considerations for patients and practitioners
Authors
Deepa H. Chand
Rudolph P. Valentini
Elaine S. Kamil
Publication date
01-06-2009
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 6/2009
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-0812-3

Other articles of this Issue 6/2009

Pediatric Nephrology 6/2009 Go to the issue